Science

BioWorld MedTech’s Cardiology Extra for Feb. 10, 2020

February 10, 2020

Keeping you up to date on recent developments in cardiology, including: Researchers find 'first responder' that triggers plaques; Heart muscle cells alter their energy source during regeneration; More evidence points to rosiglitazone, heart issues.

Science-Credit-University-of-Texas-Southwestern-Medical-Center-2-10

Decoding depression

EEG signature can predict response to SSRIs

February 10, 2020

By Anette Breindl

No Comments

For depression, and other mental health disorders, the era of precision medicine has yet to arrive. Symptoms are “very poorly reflective of the underlying biology,” Amit Etkin told BioWorld. Depression can manifest through multiple different symptoms that differ both between and within cultures.

BioWorld MedTech’s Neurology Extra for Feb. 7, 2020

February 7, 2020

By Andrea Applegate and Anette Breindl

No Comments

Keeping you up to date on recent developments in neurology, including: Online therapy for lingering depression could fill gap in care; UTHealth develops technology to differentiate between PD and multiple system atrophy; Myelin is deregulated in autism spectrum disorder.

Bench Press for Feb. 7, 2020

February 7, 2020

By Anette Breindl

No Comments

BioWorld looks at translational medicine, including: CD47 knockout improves antitumor vaccine; Multiple edits make for durable T cells; Endothelial cells have functional deficits in progeria; Myelin is deregulated in autism spectrum disorder; More enhancers suggest more pathogenicity: study; Just the vesicles, please; Distinguishing real from backseat drivers; Blocking bad bone; Plexin D1 is receptor and mechanosensor in 1; Monocytes have it both ways in DMD.

BioWorld MedTech’s Diagnostics Extra for Feb. 6, 2020

February 6, 2020

By Meg Bryant and Anette Breindl

No Comments

Keeping you up to date on recent developments in diagnostics, including: Raman spectroscopy to monitor blood glucose; A score to predict progressive chronic liver disease; From African genomes, big insights with small sample size.

Not yet a pandemic, 2019-nCoV has echoes of MERS, SARS, flu

February 5, 2020

By Anette Breindl

No Comments

The drug screens prompted by the SARS and MERS outbreaks have been useful for quickly identifying drug candidates. But in terms of their epidemiology, “SARS and MERS were different from this coronavirus,” Allison McGeer explained at a Feb. 3 webinar by Evercore ISI.

Pan-Cancer Project looks closer, sees more

February 5, 2020

By Nuala Moran

No Comments

LONDON – The genomes of 38 different tumor types and the 47 million mutations that fostered their growth are revealed in unprecedented detail in 23 studies published in Nature and other journals on Feb. 6, 2020.

BioWorld MedTech’s Orthopedics Extra for Feb. 5, 2020

February 5, 2020

By Holland Johnson

No Comments

Keeping you up to date on recent developments in orthopedics, including: After a bone injury, shape-shifting cells rush to the rescue; Machine-learning tool identified predictive factors associated with worse patient outcomes after arthroscopic hip surgery; New injection technique may boost spinal cord injury repair efforts; Does tramadol increase hip fracture risk?

Ebola, malaria, HIV, TCM

Researchers cast wide net for rapid-draw weapons in 2019-nCoV fight

February 4, 2020

By Anette Breindl

No Comments

At this very early point in the emerging 2019-nCoV outbreak, knowledge about the virus is insufficient to predict what shape that outbreak will ultimately take. But knowledge about the virus is accumulating at remarkable speed, and experience with other viruses is helping to shape the response to the newest coronavirus threat. 2019-nCoV, sometimes called Wuhan coronavirus after its source, is the third coronavirus after SARS-CoV and MERS-CoV with the potential to cause serious illness and death that has emerged since the beginning of the 21st century.

BioWorld MedTech’s Oncology Extra for Feb. 4, 2020

February 4, 2020

By Mark McCarty and Anette Breindl

No Comments

Keeping you up to date on recent developments in oncology, including: New algorithm can distinguish between subtypes in low-grade glioma; Different drivers can turn the wheel in glioblastoma’s vicious cycle; Commercial antibodies underwhelm for studies of PP2A; Foundation awards more than $1M for cancer research; Protons better for sparing cognitive function in pediatric patients.